Company
United StatesPublic company, NYSE: STXSStereotaxis Inc (NYSE: STXS), Saint Louis, MO – FDA Inspections
Inspection records and compliance data for Stereotaxis Inc in Saint Louis, Missouri. 1 FDA inspection on record, last inspected January 19, 2016. Publicly traded as NYSE: STXS.
Company Profile
This profile covers Stereotaxis Inc based in Saint Louis, Missouri, United States.
FDA Inspection History
- FDA inspections
- 1
- OAI
- 0
- VAI
- 0
- NAI
- 1
- Form 483s
- 0
- Warning letters
- 0
Inspected January 19, 2016.
FDA inspections (1)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| January 19, 2016 | NAI | Medical Devices & Rad Health · Postmarket Assurance: Devices | 961109 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Stereotaxis Inc
Stock ticker
STXS
Exchange
NYSE
Share price
$0.85
Market cap
$85.0M
Price as of
November 13, 2026
FEI Number
3003084417
Address
710 N Tucker Blvd Ste 110, Saint Louis, Missouri 63101, United States
Country
United States
ID: 9203ef93-f9c1-475b-b5d5-75508bc3b2e6